AR053372A1 - Proteinas inmunologicas de lawsonia intracellularis - Google Patents
Proteinas inmunologicas de lawsonia intracellularisInfo
- Publication number
- AR053372A1 AR053372A1 ARP060101737A ARP060101737A AR053372A1 AR 053372 A1 AR053372 A1 AR 053372A1 AR P060101737 A ARP060101737 A AR P060101737A AR P060101737 A ARP060101737 A AR P060101737A AR 053372 A1 AR053372 A1 AR 053372A1
- Authority
- AR
- Argentina
- Prior art keywords
- seq
- sequence
- polypeptide
- sequence homology
- amino acid
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/12—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
- G01N33/56911—Bacteria
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2469/00—Immunoassays for the detection of microorganisms
- G01N2469/20—Detection of antibodies in sample from host which are directed against antigens from microorganisms
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Molecular Biology (AREA)
- Immunology (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Biochemistry (AREA)
- Hematology (AREA)
- Biomedical Technology (AREA)
- Urology & Nephrology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Genetics & Genomics (AREA)
- Biophysics (AREA)
- Tropical Medicine & Parasitology (AREA)
- Analytical Chemistry (AREA)
- Physics & Mathematics (AREA)
- Virology (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Biotechnology (AREA)
- Food Science & Technology (AREA)
- Cell Biology (AREA)
- Microbiology (AREA)
- Gastroenterology & Hepatology (AREA)
- Oncology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Communicable Diseases (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
En la presente se proveen secuencias de ácidos nucleicos y aminoácidos utiles como la porcion inmunogénica de vacunas o composiciones inmunogénicas efectivas para aliviar la severidad de los síntomas clínicos asociados con la infeccion de Lawsonia intracellularis, o para conferir inmunidad protectora a un animal susceptible a esta infeccion. Las secuencias de aminoácidos preferidas se seleccionan del grupo que consiste en: 1) un polipéptido que comprende una secuencia seleccionada del grupo que consiste en SEQ ID N°: 1-455, SEQ ID N° 466, o el polipéptido codificado por SEQ ID N° 456, SEQ ID N° 457 o SEQ ID N° 466; 2) cualquier polipéptido que tiene al menos 85% de homología de secuencia, más preferiblemente al menos aproximadamente 90% de homología de secuencia, aun más preferiblemente al menos aproximadamente 95% de homología de secuencia, aun más preferiblemente al menos aproximadamente 97% de homología de secuencia, aun más preferiblemente al menos aproximadamente 98% de homología de secuencia, y aun más preferiblemente al menos aproximadamente 99% de homología de secuencia con el polipéptido de 1); 3) cualquier porcion inmunogénica de los polipéptidos de 1) y/o 2); 4) la porcion inmunogénica de 3), que comprende al menos 300, 290, 280, 270, 260, 250, 240, 230, 220, 210, 200, 190, 180, 170, 160, 150, 140, 130, 120, 110, 100, 90, 80, 70, 60, 50, 45, 40, 35, 30, 25, 20, 18, 15, 13, 10, o más preferiblemente 9 aminoácidos contiguos incluidos en las secuencias de SEQ ID N° 1-455, SEQ ID N° 456, o la secuencia de aminoácidos codificada por SEQ ID N° 457 o SEQ ID N° 466; y/o 5) un polipéptido codificado por un ADN que codifica un péptido que comprende la SEQ ID N° 1-455 o SEQ ID N° 466. Por consiguiente, las secuencias de ácidos nucleicos que codifican estas proteínas, o las proteínas mismas, se incluyen en composiciones de vacunas, en combinacion con vehículos aceptables para el uso veterinario, y se las administra a un animal que las necesita.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US67580605P | 2005-04-28 | 2005-04-28 | |
US11/414,764 US20080279893A1 (en) | 2005-04-28 | 2006-04-28 | Lawsonia intracellularis immunological proteins |
Publications (1)
Publication Number | Publication Date |
---|---|
AR053372A1 true AR053372A1 (es) | 2007-05-02 |
Family
ID=38006679
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ARP060101737A AR053372A1 (es) | 2005-04-28 | 2006-04-28 | Proteinas inmunologicas de lawsonia intracellularis |
Country Status (6)
Country | Link |
---|---|
US (1) | US20080279893A1 (es) |
EP (1) | EP1877580A4 (es) |
JP (1) | JP2009509496A (es) |
AR (1) | AR053372A1 (es) |
TW (1) | TW200716166A (es) |
WO (1) | WO2006116763A2 (es) |
Families Citing this family (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8834891B2 (en) | 2005-03-14 | 2014-09-16 | Boehringer Ingelheim Vetmedica, Inc. | Immunogenic compositions comprising Lawsonia intracellularis |
US8398994B2 (en) | 2005-07-15 | 2013-03-19 | Boehringer Ingelheim Vetmedica, Inc. | Lawsonia vaccine and methods of use thereof |
US8470336B2 (en) | 2006-05-25 | 2013-06-25 | Boehringer Ingelheim Vetmedica, Inc. | Vaccination of young animals against Lawsonia intracellularis infections |
US20080241190A1 (en) * | 2006-11-13 | 2008-10-02 | Boehringer Ingelheim Vetmedica, Inc. | Vaccination of horses against lawsonia intracellularis |
EP2101815A4 (en) | 2006-12-11 | 2010-10-06 | Boehringer Ingelheim Vetmed | EFFICIENT PROCESS FOR THE TREATMENT OF PORCINE CIRCOVIRUS AND LAWSONIA INTRACELLULARIS INFECTIONS |
US8398970B2 (en) | 2007-09-17 | 2013-03-19 | Boehringer Ingelheim Vetmedica, Inc. | Method of preventing early Lawsonia intracellularis infections |
WO2010048252A1 (en) * | 2008-10-23 | 2010-04-29 | Intervet International B.V. | Lawsonia intracellularis vaccines |
US20140017268A1 (en) * | 2012-06-05 | 2014-01-16 | Regents Of The University Of Minnesota | Composition and Methods for Detecting or Preventing Lawsonia intracellularis Infections |
CL2017002196A1 (es) | 2017-08-30 | 2017-11-17 | Univ De Concepción | Vacuna recombinante contra enteropatía proliferativa en animales. |
CN112940089B (zh) * | 2021-01-27 | 2022-09-09 | 湖南康保特生物科技有限公司 | 胞内劳森菌flgE重组蛋白及胞内劳森菌抗体检测试剂盒 |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1997020050A1 (en) * | 1995-11-30 | 1997-06-05 | Daratech Pty. Ltd. | Therapeutic and diagnostic compositions |
EP1570045A4 (en) * | 2002-10-04 | 2007-09-05 | Univ Minnesota | NUCLEIC ACID AND POLYPEPTIDE SEQUENCES FROM LAWSONIA INTRACELLULARIS AND METHOD OF USE |
-
2006
- 2006-04-28 AR ARP060101737A patent/AR053372A1/es unknown
- 2006-04-28 TW TW095115374A patent/TW200716166A/zh unknown
- 2006-04-28 US US11/414,764 patent/US20080279893A1/en not_active Abandoned
- 2006-04-28 JP JP2008509226A patent/JP2009509496A/ja not_active Withdrawn
- 2006-04-28 WO PCT/US2006/016559 patent/WO2006116763A2/en active Application Filing
- 2006-04-28 EP EP06751971A patent/EP1877580A4/en not_active Withdrawn
Also Published As
Publication number | Publication date |
---|---|
TW200716166A (en) | 2007-05-01 |
WO2006116763A3 (en) | 2007-11-08 |
US20080279893A1 (en) | 2008-11-13 |
EP1877580A2 (en) | 2008-01-16 |
WO2006116763A2 (en) | 2006-11-02 |
JP2009509496A (ja) | 2009-03-12 |
EP1877580A4 (en) | 2008-07-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AR053372A1 (es) | Proteinas inmunologicas de lawsonia intracellularis | |
ES2839880T3 (es) | Vacuna contra el VRS | |
HRP20191594T1 (hr) | Poticanje imunosnog odgovora | |
AR107020A2 (es) | Vacuna de pcsk9 (proteína convertasa subtilisina-kexina tipo 9) | |
AR064642A1 (es) | Polinucleotido vector que lo comprende celula recombinante que comprende el vector polipeptido , anticuerpo , composicion que comprende el polinucleotido , vector , celula recombinante polipeptido o anticuerpo , uso de la composicion y metodo para preparar la composicion misma y preparar una composi | |
HRP20231496T1 (hr) | Cistein proteaza | |
PE20140986A1 (es) | Proteinas de fusion y vacunas de combinacion que comprenden proteina e y pilina a de haemophilus influenzae | |
RU2015142981A (ru) | Белки rsv в предшествующей слиянию конформации и их применение | |
JP2014534202A5 (es) | ||
HRP20140109T1 (hr) | Novi imunoadjuvantni spojevi na bazi flagelina i njihova upotreba | |
SI2280721T1 (en) | IMUNOTHERAPY BASED ON INDOLEAMINE 2,3-DIOXYGENESIS | |
ATE470673T1 (de) | Impfstoffe mit lawsoniaintrazellularis- untereinheit | |
AR083839A1 (es) | Virus del sindrome reproductivo y respiratorio porcino (prrs) de los estados unidos y sus usos | |
JP2020509770A5 (es) | ||
AR094725A1 (es) | Parvovirus 5a porcino, métodos de uso y vacuna | |
PE20061441A1 (es) | Genes y proteinas novedosos de brachyspira hyodysenteriae y uso de los mismos para diagnostico y terapia | |
NZ598605A (en) | Vaccine against african horse sickness virus | |
JP2012516140A5 (es) | ||
AR071696A1 (es) | Vacuna contra leishmania usando un inmunogeno salival de la mosca de la arena. metodos. | |
AR123187A1 (es) | Vacuna de múltiples epítopos para el tratamiento de la enfermedad de alzheimer | |
ATE435660T1 (de) | Immunogenes polypeptid bestehend aus optimierten kryptischen peptiden aus tumorantigenen und seine verwendungen | |
WO2006113782A3 (en) | Lawsonia protein useful as a component in subunit vaccine and methods of making and using thereof | |
ATE450545T1 (de) | Impfstoff mit lawsonia intracellularis- untereinheit | |
RU2009115688A (ru) | Иммуногенные гибридные полипептиды против ожирения и композиция вакцин против ожирения, содержащая эти полипептиды | |
TW200801034A (en) | Novel sea lice vaccine |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FB | Suspension of granting procedure |